Clinical Trial 41706

Atlanta, GA 30328


Is another clostridium difficile infection getting in the way of your life?

Consider this medical research study of an investigational medication that may help prevent these infections from recurring.

When you or someone you care about has a Clostridium difficile infection (CDI), the effects can be difficult to handle. Every day, a person can experience diarrhea that is frequent, out of control, and worst of all, can begin without any warning.

For adults who live with recurrent CDI, doctors and researchers are conducting the ECOSPOR III medical research study. In this study, investigators want to evaluate the safety and effectiveness of an investigational medication to see if it helps prevent recurring episodes of CDI.

If you are interested in participating in our Clostridium Difficile (C. Diff) study, please fill out the form below.

Qualified Participants Must:

• Be 18 years of age or older
• Have a documented history of a least 3 episodes of CDI in the last 9 months, including the current episode

Qualified Participants May Receive:

Compensation for time and travel.

All study-related visits, tests, and medication will be provided to participants at no cost. Reimbursement for time and travel may be provided.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.